Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernán, M. A.
Right arrow Articles by Rodríguez, L. A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernán, M. A.
Right arrow Articles by Rodríguez, L. A. G.
NEUROLOGY 2006;66:1097-1099
© 2006 American Academy of Neurology
Brief Communications

Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease

Miguel A. Hernán, MD, Giancarlo Logroscino, MD and Luis A. García Rodríguez, MD

From the Department of Epidemiology (M.A.H., G.L.), Harvard School of Public Health, Boston, MA; and Centro Español de Investigación Farmacoepidemiológica (L.A.G.R.), Madrid, Spain.

Address correspondence and reprint requests to Dr. Miguel Hernán, Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115; e-mail: miguel_hernan{at}post.harvard.edu

Animal and epidemiologic studies suggest that nonsteroidal anti-inflammatory drugs (NSAIDs) decrease the incidence of Parkinson disease (PD). The authors studied 1,258 PD cases and 6,638 controls from the General Practice Research Database. The odds ratios (95% CI) for ever vs never use were 0.93 (0.80 to 1.08) for nonaspirin NSAIDs, 1.29 (1.05 to 1.58) for aspirin, and 1.16 (1.00 to 1.35) for acetaminophen. Nonaspirin NSAID use was associated with a higher risk in women and a lower risk in men.

Disclosure: The authors report no conflicts of interest.

Received September 15, 2005. Accepted in final form December 2, 2005.




This article has been cited by other articles:


Home page
 NeurologyHome page
C. Becker, S. S. Jick, and C. R. Meier
Use of antihypertensives and the risk of Parkinson disease
Neurology, April 15, 2008; 70(16_Part_2): 1438 - 1444.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. D. Wahner, J. M. Bronstein, Y. M. Bordelon, and B. Ritz
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Neurology, November 6, 2007; 69(19): 1836 - 1842.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Alonso, L. A. G. Rodriguez, G. Logroscino, and M. A. Hernan
Gout and risk of Parkinson disease: A prospective study
Neurology, October 23, 2007; 69(17): 1696 - 1700.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
D. B. Hancock, E. R. Martin, J. M. Stajich, R. Jewett, M. A. Stacy, B. L. Scott, J. M. Vance, and W. K. Scott
Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease
Arch Neurol, April 1, 2007; 64(4): 576 - 580.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.